Shandong Xinhua Pharmaceutical Co., Ltd

Hualu Network Group 中文版

Investor Relation

Information transparency and trust in peers

Investor Relation

PERIODIC REPORT

Notice of The Annual General Meeting

Notice of The Annual General Meeting

Proposed Amendments To The Articles of Association And Notice of The Annual General Meeting

Unaudited First Quarter Results of 2025

Unaudited First Quarter Results of 2025

Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Overseas Regulatory Announcement-Announcement on New Specifications of Aspirin Enteric-coated Tablets passing the Generics Drugs Consistency Evaluation

Reminder Letter and Reply Form to Non-registered Shareholders - Reminder Letter Regarding the Arrangement of Electronic Dissemination of Corporate Communications

Reminder Letter and Reply Form to Non-registered Shareholders - Reminder Letter Regarding the Arrangement of Electronic Dissemination of Corporate Communications

Reminder Letter and Reply Form to Registered Shareholders - Reminder Letter Regarding the Arrangement of Electronic Dissemination of Corporate Communications

Reminder Letter and Reply Form to Registered Shareholders - Reminder Letter Regarding the Arrangement of Electronic Dissemination of Corporate Communications

Overseas Regulatory Announcement-Announcement on Pentazocine Injection Having Obtained the Drug Registration Certificate

Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2025

总条数: 23条

＜ 1 2 3 ＞

跳转到: 页